Futura Medical CEO James Barder on Futura’s 2024 strong growth, maiden profit and 2025 plans
15 April 2025
Futura Medical announces enhanced Eroxon Gel for ED and female sexual dysfunction product
04 November 2024
Futura Medical achieves milestone with first profit as it eyes US Eroxon launch
10 September 2024
Futura Medical targets global expansion with Eroxon, eyeing profitability in 2024
10 April 2024
Futura Medical marks pivotal year with first meaningful revenue from Eroxon sales
07 February 2024
Futura Medical continues global expansion with Latin America announcement
07 November 2023
Proactive Investor Video
September 2023
Futura Medical PLC - Interim Results 2023
September 2023
Fireside Chat with James Barder, CEO of Futura Medical
July 2023
Futura Medical "absolutely delighted" with US commercialisation agreement
18 July 2023
Futura Medical in discussions with US partners after gaining FDA approval
June 2023
Futura Medical debuts Eroxon in UK and says "more launches coming"
April 2023
Futura Medical expects FDA approval for topical ED treatment during Q2
March 2023